PHARMACY

Specialty Pharmacy Summit to take place in March

BY Alaric DeArment

SHORT HILLS, N.J. A large specialty pharmacy network and group-contracting organization will be host of the fifth annual Specialty Pharmacy Summit in March.

Armada Health Care announced Tuesday that the summit would take place at the Wynn Hotel in Las Vegas from March 10 to March 13. Armada expects almost 1,000 people to attend, and they will represent more than 50 percent of the total annual expenditure on specialty pharmacy in the United States. Last year’s summit included more than 500 specialty pharmacy providers, industry-channel partners and representatives of industry-associated vendors, as well as PBMs and insurers.

Armada said the summit would give specialty pharmacy providers an opportunity to evaluate new products, gain knowledge of industry trends and network with peers, payers and vendors.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Rite Aid upgrades cash registers to support FSA cards

BY Antoinette Alexander

CAMP HILL, Pa. Rite Aid has upgraded its pharmacy and front-end cash registers to make it easier for shoppers to use their Flexible Spending Account debit cards.

The pharmacy retailer is utilizing an inventory information approval system to allow customers to pay for eligible healthcare items with FSA debit cards. Eligible healthcare purchases on receipts are identified with an H to the right of the item’s price. These items are tallied by the cash register and can be paid for by an FSA debit card. The remaining balance for non-eligible items is paid for separately.

The FSA debits cards work similar to other debit cards and allow customers to buy certain health items using funds from a pre-tax accounts.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

FDA delays approval of Remoxy painkiller

BY Alaric DeArment

NEW YORK The Food and Drug Administration announced that it needed more clinical studies of the pain pill Remoxy before it would approve it.

The pill, a formulation of oxycodone by King Pharmaceuticals and Pain Therapeutics, is designed in a capsule form that prevents abuse by people trying to get high.

On Wednesday, King Pharmaceuticals’ shares were down by 83 cents, at $9.13, and Pain Therapeutics were down by $1.82, at $5.93.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?